Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168. Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen. Podcast Sep 2022 Ethics Teaching and Learning: Updated Lessons for Clinicians and Students From a Transgender Patient Ryan Sallans, MA joins Ethics Teaching and Learning to discuss how to make health care spaces welcoming for LGBTQ+ patients. Case and Commentary Jun 2023 How Should a Transgender Patient’s History of Deep Vein Thrombosis and Smoking Influence Gender-Affirming Health Decision Sharing? Rebkah Tesfamariam and Joshua D. Safer, MD This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy. AMA J Ethics. 2023;25(6):E386-390. doi: 10.1001/amajethics.2023.386. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168.
Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen.
Podcast Sep 2022 Ethics Teaching and Learning: Updated Lessons for Clinicians and Students From a Transgender Patient Ryan Sallans, MA joins Ethics Teaching and Learning to discuss how to make health care spaces welcoming for LGBTQ+ patients.
Case and Commentary Jun 2023 How Should a Transgender Patient’s History of Deep Vein Thrombosis and Smoking Influence Gender-Affirming Health Decision Sharing? Rebkah Tesfamariam and Joshua D. Safer, MD This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy. AMA J Ethics. 2023;25(6):E386-390. doi: 10.1001/amajethics.2023.386.